Encouraging News From the SERM Frontier

This publication has 10 references indexed in Scilit:

• The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial
  Obstetrical & Gynecological Survey, 2000
• Effect of Estrogen on Brain Activation Patterns in Postmenopausal Women During Working Memory Tasks
  JAMA, 1999
• Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women
  Psychoneuroendocrinology, 1998
• Treatment of Established Postmenopausal Osteoporosis with Raloxifene: A Randomized Trial
  Journal of Bone and Mineral Research, 1998
• Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
  JNCI Journal of the National Cancer Institute, 1998
• Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
  JAMA, 1998
• Effects of Raloxifene on Serum Lipids and Coagulation Factors in Healthy Postmenopausal Women
  JAMA, 1998
• Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
  New England Journal of Medicine, 1997
• The effect of estrogen replacement therapy on cognitive function in women: A critical review of the literature
  Journal of Clinical Epidemiology, 1997
• Coronary heart disease and estrogen replacement therapy can compliance bias explain the results of observational studies?
  Annals of Epidemiology, 1994